Labeler
BluePoint Laboratories NDC Codes
BluePoint Laboratories lists 349 finished drug products in the FDA NDC Directory under NDC labeler code 68001.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Enoxaparin Sodium, Nadolol, Dasatinib, doxorubicin hydrochloride, Metoprolol Succinate, Aprepitant, Zenatane, Decitabine, Labetalol Hydrochloride, Cyclophosphamide, Fluoxetine, Etoposide, Haloperidol decanoate, leucovorin calcium, Mitomycin
- Active ingredients
- Enoxaparin sodium, Nicotine, Nadolol, Dasatinib, Doxorubicin hydrochloride, Metoprolol succinate, Isotretinoin, Decitabine, Labetalol hydrochloride, Cyclophosphamide, Aprepitant, Fluoxetine hydrochloride
- NDC labeler codes
- 68001
- Strengths (from the 100 most recently listed products)
- Doxorubicin hydrochloride 2 mg/mL; Enoxaparin sodium 100 mg/mL; Etoposide 20 mg/mL; Decitabine 50 mg/10mL; Nicotine 7 mg/24h; Nicotine 14 mg/24h; Nicotine 21 mg/24h; Nadolol 20 mg/1; Nadolol 40 mg/1; Nadolol 80 mg/1; Enoxaparin sodium 150 mg/mL; Fluorouracil 50 mg/mL; Cisplatin 1 mg/mL; Palonosetron hydrochloride .25 mg/5mL; Labetalol hydrochloride 300 mg/1; Paclitaxel 6 mg/mL; Teriparatide 250 ug/mL; Cyclophosphamide 500 mg/25mL; Cyclophosphamide 1 g/50mL; Cyclophosphamide 2 g/100mL
- Dosage forms
- Injection, Tablet, Tablet, Film coated, Injection, Powder, Lyophilized, For solution, Patch, Extended release, Capsule, Injection, Solution, Tablet, Extended release, Capsule, Gelatin coated, Injection, Solution, Concentrate, Injection, Suspension, Liposomal, Injection, Powder, For solution, Injectable, Liposomal, Solution, Tablet, Film coated, Extended release, Kit, Patch, Injection, Powder, Lyophilized, For suspension, Gel, Spray, Capsule, Extended release
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Transdermal, Topical, Ophthalmic, Nasal
- Drug classes (FDA established)
- beta-Adrenergic Blocker, Nucleoside Metabolic Inhibitor, Kinase Inhibitor, Low Molecular Weight Heparin, Cholinergic Nicotinic Agonist, Anthracycline Topoisomerase Inhibitor, Serotonin Reuptake Inhibitor, Substance P/Neurokinin-1 Receptor Antagonist, Retinoid, Microtubule Inhibitor, Topoisomerase Inhibitor, Typical Antipsychotic, Folate Analog, Alkylating Drug, Anti-epileptic Agent, Mood Stabilizer, Nonsteroidal Anti-inflammatory Drug, Aminoketone, Bisphosphonate, Platinum-based Drug, Serotonin-3 Receptor Antagonist, Parathyroid Hormone Analog, Histamine-1 Receptor Antagonist, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Cytochrome P450 17A1 Inhibitor, Amide Local Anesthetic, Antiarrhythmic, Corticosteroid, Opioid Antagonist, Vitamin B12, Estrogen Receptor Antagonist, Osmotic Laxative, Potassium Salt
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 131 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Escitalopram | Escitalopram oxalate 20 mg/1 | Tablet, Film coatedOral | 68001-593 | 68001-0593-0068001-0593-08 | — |
| Quetiapine | Quetiapine fumarate 50 mg/1 | Tablet, Extended releaseOral | 68001-598 | 68001-0598-06 | — |
| Quetiapine | Quetiapine fumarate 150 mg/1 | Tablet, Extended releaseOral | 68001-599 | 68001-0599-06 | — |
| Quetiapine | Quetiapine fumarate 200 mg/1 | Tablet, Extended releaseOral | 68001-600 | 68001-0600-06 | — |
| Quetiapine | Quetiapine fumarate 300 mg/1 | Tablet, Extended releaseOral | 68001-601 | 68001-0601-06 | — |
| Quetiapine | Quetiapine fumarate 400 mg/1 | Tablet, Extended releaseOral | 68001-602 | 68001-0602-06 | — |
| Nitrofurantoin (monohydrate/macrocrystals) | Nitrofurantoin monohydrate 75 mg/1; Nitrofurantoin 25 mg/1 | CapsuleOral | 68001-606 | 68001-0606-00 | — |
| nitrofurantoin macrocrystals | Nitrofurantoin 25 mg/1 | CapsuleOral | 68001-603 | 68001-0603-00 | — |
| nitrofurantoin macrocrystals | Nitrofurantoin 50 mg/1 | CapsuleOral | 68001-604 | 68001-0604-00 | — |
| nitrofurantoin macrocrystals | Nitrofurantoin 100 mg/1 | CapsuleOral | 68001-605 | 68001-0605-00 | — |
| Polyethylene Glycol 3350 | Polyethylene glycol 3350 17 g/17g | Powder, For solutionOral | 68001-607 | 68001-0607-5568001-0607-69 | — |
| bendamustine hydrochloride | Bendamustine hydrochloride 100 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-572 | 68001-0572-41 | — |
| Haloperidol Decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | 68001-578 | 68001-0578-48 | — |
| Haloperidol Decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | 68001-579 | 68001-0579-48 | — |
| Glimepiride | Glimepiride 1 mg/1 | TabletOral | 68001-584 | 68001-0584-0068001-0584-03 | — |
| Glimepiride | Glimepiride 2 mg/1 | TabletOral | 68001-585 | 68001-0585-0068001-0585-03 | — |
| Glimepiride | Glimepiride 4 mg/1 | TabletOral | 68001-586 | 68001-0586-0068001-0586-03 | — |
| Clonidine hydrochloride | Clonidine hydrochloride .1 mg/1 | Tablet, Extended releaseOral | 68001-568 | 68001-0568-06 | — |
| Haloperidol Decanoate | Haloperidol decanoate 500 mg/5mL | InjectionIntramuscular | 68001-582 | 68001-0582-41 | — |
| Isosorbide dinitrate | Isosorbide dinitrate 30 mg/1 | TabletOral | 68001-562 | 68001-0562-00 | — |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | 68001-469 | 68001-0469-0068001-0469-08 | — |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | 68001-470 | 68001-0470-0068001-0470-08 | — |
| Metoprolol Succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | 68001-471 | 68001-0471-00 | — |
| Desmopressin Acetate | Desmopressin acetate .1 mg/1 | TabletOral | 68001-574 | 68001-0574-00 | — |
| Desmopressin Acetate | Desmopressin acetate .2 mg/1 | TabletOral | 68001-575 | 68001-0575-00 | — |
| Haloperidol Decanoate | Haloperidol decanoate 50 mg/mL | InjectionIntramuscular | 68001-580 | 68001-0580-41 | — |
| Haloperidol Decanoate | Haloperidol decanoate 100 mg/mL | InjectionIntramuscular | 68001-581 | 68001-0581-4168001-0581-4868001-0581-82 | — |
| Duloxetine | Duloxetine hydrochloride 40 mg/1 | Capsule, Delayed releaseOral | 68001-570 | 68001-0570-04 | — |
| Duloxetine | Duloxetine hydrochloride 20 mg/1 | Capsule, Delayed releaseOral | 68001-594 | 68001-0594-06 | — |
| Duloxetine | Duloxetine hydrochloride 30 mg/1 | Capsule, Delayed releaseOral | 68001-595 | 68001-0595-0468001-0595-0568001-0595-08 | — |
| Duloxetine | Duloxetine hydrochloride 60 mg/1 | Capsule, Delayed releaseOral | 68001-596 | 68001-0596-0468001-0596-08 | — |
| Sildenafil | Sildenafil citrate 20 mg/1 | Tablet, Film coatedOral | 68001-597 | 68001-0597-05 | — |
| Decitabine | Decitabine 50 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-573 | 68001-0573-41 | — |
| Hydrocortisoneantipruritic (anti-itch) | Hydrocortisone acetate 1 g/100g | OintmentTopical | 68001-526 | 68001-0526-45 | — |
| Cyclophosphamide | Cyclophosphamide anhydrous 200 mg/mL | Injection, SolutionIntravenous | 68001-564 | 68001-0564-22 | — |
| Cyclophosphamide | Cyclophosphamide anhydrous 200 mg/mL | Injection, SolutionIntravenous | 68001-565 | 68001-0565-28 | — |
| Guaifenesin | Guaifenesin 600 mg/1 | Tablet, Extended releaseOral | 68001-561 | 68001-0561-17 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 750 mg/30mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-545 | 68001-0545-41 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 1000 mg/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-546 | 68001-0546-41 | — |
| Childrens Ibuprofenibuprofen | Ibuprofen 100 mg/5mL | SuspensionOral | 68001-521 | 68001-0521-9268001-0521-94 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-544 | 68001-0544-41 | — |
| Bortezomib | Bortezomib 3.5 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 68001-534 | 68001-0534-36 | — |
| Bortezomib | Bortezomib 3.5 mg/3.5mL | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 68001-541 | 68001-0541-36 | — |
| Pemetrexed | Pemetrexed disodium hemipentahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-535 | 68001-0535-41 | — |
| Pemetrexed | Pemetrexed disodium hemipentahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-536 | 68001-0536-41 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-538 | 68001-0538-41 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium hemipentahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-539 | 68001-0539-41 | — |
| Cyanocobalamin | Cyanocobalamin 1000 ug/mL | Injection, SolutionSubcutaneous | 68001-542 | 68001-0542-60 | — |
| Pemetrexedpemetrexed disodium | Pemetrexed disodium 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-543 | 68001-0543-41 | — |
| Bortezomib | Bortezomib 3.5 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous, Subcutaneous | 68001-540 | 68001-0540-36 | — |
BluePoint Laboratories: common questions
- What is BluePoint Laboratories's NDC labeler code?
- 68001. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for BluePoint Laboratories?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.